Serum
Chlamydia Pneumoniae IgG Antibody, Serum
Test Name: Chlamydia Pneumoniae IgG Antibody, Serum
Overview
The Chlamydia Pneumoniae IgG Antibody test measures IgG antibodies in the blood against Chlamydia pneumoniae, a bacterium that commonly causes respiratory tract infections such as pneumonia, bronchitis, sinusitis, and pharyngitis. The presence of IgG antibodies generally indicates past exposure or previous infection and may persist for months or years after infection.
Why This Test Is Done
- To evaluate previous exposure to Chlamydia pneumoniae.
- To assist in the diagnosis of respiratory infections when used along with clinical findings and other laboratory tests.
- To help distinguish between past and recent infection when combined with IgM and/or IgA antibody testing.
- To investigate chronic or recurrent respiratory symptoms potentially associated with Chlamydia pneumoniae infection.
Symptoms That May Prompt Testing
- Persistent cough
- Sore throat
- Fever
- Fatigue
- Shortness of breath
- Bronchitis-like symptoms
- Community-acquired pneumonia
Sample Required
-
Specimen: Serum
-
Method: Immunoassay (method may vary by laboratory)
Understanding the Results
-
Negative: No detectable IgG antibodies; suggests no prior exposure or antibodies are below detectable levels.
-
Positive: Indicates previous exposure or past infection with Chlamydia pneumoniae.
-
Rising IgG Levels (paired samples): May suggest a recent or ongoing infection when compared with earlier results.
Clinical Significance
- IgG antibodies typically appear several weeks after infection and can remain detectable for extended periods.
- A positive IgG result alone does not necessarily indicate an active infection.
- Interpretation should be made alongside symptoms, medical history, and other laboratory findings.
Preparation
- No special preparation or fasting is usually required.
- Inform your healthcare provider about any medications or ongoing infections.
Turnaround Time
- Typically 1–3 days, depending on the laboratory.
This test is commonly used as part of the diagnostic evaluation of atypical respiratory infections and may be combined with IgM and IgA antibody testing for a more complete assessment.